The current study revealed additional pro-inflammatory properties of DNA-PKcs in myocardial microvessels and suggested that DNA-PKcs inactivation could be a worthwhile therapeutic strategy to interrupt pro-inflammatory signal transduction during endotoxemia-induced microvascular injury. Here, PRKDC is linked to serum lipopolysaccharide activity.